register

Digital & Innovation

AstraZeneca and AbbVie industry experts talk accelerated digital transformation at Digital Acceleration Roundtable Series

Health Industry Hub | March 29, 2021 |

Digital & Innovation: The COVID-19 pandemic has pushed pharma companies over the technology tipping point and accelerated the digital transformation journey in several areas of their business including commercial and marketing. 

Alida Rossi, Commercial Excellence Director at AbbVie and Charles Waterfield, Commercial Excellence & Innovation Director at AstraZeneca join Health Industry Hub Founder Rozalina Sarkezians and co-host Peter Stephenson from West 53rd St Digital to discuss the fast-changing digital landscape that is re-shaping customer engagement models and driving innovation in the ‘new normal’.

Alida and Charles discussed the key organisational learnings during COVID-19, the role of the commercial teams and how digital will support this evolution, and the biggest challenges facing marketers in strategic planning for customer engagement. They also reflected on the importance of leadership commitment and an agile mindset in enhancing the resources and investment required for the accelerated digital journey.


News & Trends - MedTech & Diagnostics

Aussie medtech forges ahead, making inroads with new technology

Aussie medtech forges ahead, making inroads with new technology

Health Industry Hub | February 23, 2024 |

MedTech & Diagnostics News: Adelaide-based medical technology firm, LBT Innovations has successfully delivered its cutting-edge Automated Plate Assessment System (APAS) […]

More


News & Trends - Pharmaceuticals

Is the imposed PBS funding cap driving the migraine medicines shortage?

Is the imposed PBS funding cap driving the migraine medicines shortage?

Health Industry Hub | February 23, 2024 |

Pharma News: Australia finds itself grappling with an unparalleled shortage of migraine prevention medicines, leaving a significant impact on the […]

More


News & Trends - Pharmaceuticals

MSAC rejects Janssen's CAR T therapy despite clinical superiority, citing need for 'substantial price reduction'

MSAC rejects Janssen’s CAR T therapy despite clinical superiority, citing need for ‘substantial price reduction’

Health Industry Hub | February 23, 2024 |

Pharma News: The Medical Services Advisory Committee (MSAC) has deferred its decision on whether Janssen’s CAR T-cell therapy Carvykti (cilta-cel) […]

More


News & Trends - Pharmaceuticals

Gedeon Richter secures first endometriosis treatment in over a decade, with experts pushing for extension of NAPE

Gedeon Richter secures first endometriosis treatment in over a decade, with experts pushing for extension of NAPE

Health Industry Hub | February 23, 2024 |

Pharma News: The Therapeutic Goods Administration (TGA) has granted approval for the first endometriosis treatment in 13 years. Gedeon Richter […]

More


This content is copyright protected. Please subscribe to gain access.